TOG Review (RCOG Journal)
MRCOG Part 2
Urogynaecology and Pelvic Floor Problems
Management of uterine prolapse
Key Statistics
- 10–40% — Recurrence after vaginal hysterectomy
- 92% — Satisfaction, pessary use (n=100)
- 89% — 'Much/very much better', lap. hysteropexy (n=140)
Don't-miss facts
-
Fertility preservation = the one absolute indication for hysteropexy
-
Vaginal hysterectomy recurrence rate 10–40% – does not fix underlying connective tissue deficiency
-
RCOG: sacrospinous fixation if vault at introitus at end of vaginal hysterectomy
-
Roovers et al.: sacrohysteropexy recurrence 22% vs vaginal hysterectomy + vault fixation 2.5%
-
Contraindications to preservation: cervical dysplasia, abnormal uterine bleeding, possibly large fibroids/uterine anomalies
-
Oxford hysteropexy mesh encircles cervix → vaginal delivery not possible, caesarean required
-
Transvaginal mesh erosion up to 10%; abdominal/sacrocolpopexy mesh extrusion 2–11%
-
Colpocleisis: 98% anatomical success, 92% satisfaction, but loss of sexual function and future cervical/uterine access
Recurrence at a glance
Vaginal hysterectomy alone: 10–40% Vaginal hysterectomy + vault fixation: 2.5% Abdominal sacrohysteropexy: 22%
Oxford lap. hysteropexy (apical): 4%
Abbreviation Key
- RCT — randomised controlled trial
- ICIQ-VS — International Consultation on Incontinence Questionnaire – Vaginal Symptoms
- POP-Q — pelvic organ prolapse quantification system
- VUE study — Vault or Uterine prolapse surgery Evaluation study
- RCOG — Royal College of Obstetricians and Gynaecologists
- MHRA — Medicines and Healthcare Products Regulatory Agency
- ATSM — advanced training skills module
- BMI — body mass index
Source: Jefferis H, Jackson SR, Price N. Management of uterine prolapse: is hysterectomy necessary? The Obstetrician & Gynaecologist 2016;18:17–23. doi:10.1111/tog.12220
MRCOG AI is an independent educational tool. It is not affiliated with, endorsed by, or connected to the Royal College of Obstetricians and Gynaecologists (RCOG).